5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors

Clinical trial NCT07404332 · RECRUITING

Trial details

NCT number: NCT07404332
Sponsor: Mohammed Milhem
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Locally Advanced Solid Tumor Metastatic Tumor

Start date: 2026-02-11
Primary completion: 2028-02-28
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.